Date: 2014-11-06 23:51:26

Biotechnology

Healthcare in Australia

Bristol-Myers Squibb

Cetuximab

KRAS

Panitumumab

Colorectal cancer

Biomarker

Pharmaceutical Benefits Scheme

Medicine

Biology

Health

Public Summary Document Application No[removed]KRAS mutation testing for panitumumab Sponsor/Applicant/s: Amgen Australia

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 58,65 KB